世界のスマート吸入器市場予測2019-2028

◆英語タイトル:GLOBAL SMART INHALERS MARKET FORECAST 2019-2028
◆商品コード:INK20AG021
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年7月
◆ページ数:192
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥262,500見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥315,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥472,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、スマート吸入器の世界市場について調査を行い、調査手法、エグゼクティブサマリー、市場動向、主要分析、製品別(スマート吸入器、スマートネブライザー)分析、疾患別分析、流通チャネル別分析、地域別分析、企業情報などをまとめております。
・調査手法
・エグゼクティブサマリー
・市場動向
・主要分析
・スマート吸入器の世界市場規模:製品別(スマート吸入器、スマートネブライザー)
・スマート吸入器の世界市場規模:疾患別
・スマート吸入器の世界市場規模:流通チャネル別
・スマート吸入器の世界市場規模:地域別
・企業情報








【レポートの概要】

KEY FINDINGS
The global smart inhalers market is projected to garner considerable revenue, growing at a CAGR of 31.66%, during the forecast period of 2019 to 2028. The drivers facilitating the market growth include a high incidence of chronic respiratory diseases like Chronic Obstructive Pulmonary Disease (COPD) and asthma, an increase in air pollution, and indoor air pollutants. Moreover, the growing geriatric population has also contributed to market growth.

MARKET INSIGHTS
Smart inhalers are used to deliver a variety of medications through inhalation. The drugs in the inhalers comprise glucocorticoids, anti-cholinergic, insulin, and beta-agonists for preventing and treating respiratory conditions like asthma and COPD. The inhalers are called smart inhalers due to the sensors clipped on them, monitoring the right dose, with each intake. The data registered by the sensor is shared with the patient and healthcare professionals to measure and track the inhaler use. The monitored information is then shared using Bluetooth technology to their mobile applications through a specific platform. The global smart inhalers market growth is propelled by the upsurge in the prevalence of COPD and asthma, which is caused by an increase in air pollution. Therefore, the high rates of air pollution are anticipated to cause a rise in respiratory disorders, which stimulates market growth. However, expensive treatments and limited availability of inhalers, hinder the global smart inhalers market growth.

REGIONAL INSIGHTS
The geographical segmentation of the global smart inhalers market comprises Asia Pacific, Europe, North America, and the rest of the world. Asia Pacific is estimated to project the highest CAGR, in terms of revenue, across the forecast period. Growing pollution rates in India, have led to a hike in the prevalence of respiratory diseases. This has significantly raised the demand for smart inhalers in the country, thereby propelling the market growth.

COMPETITIVE INSIGHTS
The global smart inhalers market is highly fragmented and comprises several large-scale and small-scale industries. Thus, intense competition is witnessed among participants. Companies stimulating the market growth include, ResMed Inc (Propeller Health), Novartis AG, GlaxoSmithKline Plc, Teva Pharmaceutical Industries Limited, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. RISE IN AIR POLLUTION
3.2.2. HIGH PREVALENCE OF CHRONIC RESPIRATORY DISEASES
3.2.3. SURGING INDOOR AIR POLLUTANTS
3.2.4. RISING GERIATRIC POPULATION
3.2.5. GROWING PREVALENCE OF COPD AND ASTHMA
3.3. KEY RESTRAINTS
3.3.1. DATA SECURITY CONCERN HAMPERS THE MARKET
3.3.2. HIGH COST OF ASTHMA AND COPD TREATMENT
4. KEY ANALYTICS
4.1. PORTER’S FIVE FORCE ANALYSIS
4.1.1. THREAT OF NEW ENTRY
4.1.2. THREAT OF SUBSTITUTION
4.1.3. BUYER’S POWER
4.1.4. SUPPLIER’S POWER
4.1.5. COMPETITIVE RIVALRY
4.2. EVOLUTION OF SMART INHALERS
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
4.5. KEY INVESTMENT INSIGHTS
5. MARKET BY PRODUCT
5.1. SMART INHALERS
5.1.1. DRY POWDER INHALER
5.1.2. METERED DOSE INHALER
5.2. SMART NEBULIZER
5.2.1. TYPES OF NEBULIZER (QUALITATIVE)
5.2.1.1. PNEUMATIC NEBULIZER
5.2.1.2. ULTRASONIC NEBULIZER
5.2.1.3. MESH NEBULIZER
5.2.2. NEBULIZER BY PORTABILITY (QUALITATIVE)
5.2.2.1. TABLETOP NEBULIZER
5.2.2.2. PORTABLE NEBULIZER
5.2.3. NEBULIZER BY SALES CHANNEL (QUALITATIVE)
5.2.3.1. DIRECT PURCHASE
5.2.3.2. ONLINE PURCHASE
6. MARKET BY INDICATION
6.1. ASTHMA
6.2. COPD
7. MARKET BY DISTRIBUTION CHANNEL
7.1. HOSPITAL
7.2. PHARMACY
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. THE UNITED STATES
8.1.2. CANADA
8.2. EUROPE
8.2.1. GERMANY
8.2.2. FRANCE
8.2.3. THE UNITED KINGDOM
8.2.4. ITALY
8.2.5. RUSSIA
8.2.6. BELGIUM
8.2.7. POLAND
8.2.8. REST OF EUROPE
8.3. ASIA PACIFIC
8.3.1. JAPAN
8.3.2. CHINA
8.3.3. INDIA
8.3.4. AUSTRALIA & NEW ZEALAND
8.3.5. SOUTH KOREA
8.3.6. THAILAND
8.3.7. INDONESIA
8.3.8. VIETNAM
8.3.9. REST OF ASIA PACIFIC
8.4. REST OF WORLD
8.4.1. LATIN AMERICA
8.4.2. MIDDLE EAST & AFRICA
9. COMPANY PROFILES
9.1. 3M COMPANY
9.2. ADHERIUM LIMITED
9.3. AGILENT TECHNOLOGIES INC
9.4. ASTRAZENECA PLC
9.5. BOEHRINGER INGELHEIM GMBH
9.6. COHERO HEALTH INC
9.7. GLAXOSMITHKLINE PLC
9.8. KONINKLIJKE PHILIPS N.V
9.9. NOVARTIS AG
9.10. OPKO HEALTH INC
9.11. RESMED INC (PROPELLER HEALTH)
9.12. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
9.13. VECTURA GROUP PLC

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - SMART INHALERS
TABLE 2: GLOBAL SMART INHALERS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 3: GLOBAL SMART INHALERS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 4: GLOBAL SMART INHALERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 5: GLOBAL SMART INHALERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 6: GLOBAL SMART INHALERS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 7: GLOBAL SMART INHALERS MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 8: GLOBAL SMART NEBULIZER MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 9: GLOBAL SMART NEBULIZER MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 10: GLOBAL SMART INHALERS MARKET, BY INDICATION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 11: GLOBAL SMART INHALERS MARKET, BY INDICATION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 12: GLOBAL ASTHMA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 13: GLOBAL ASTHMA MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 14: GLOBAL COPD MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 15: GLOBAL COPD MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 16: GLOBAL SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 17: GLOBAL SMART INHALERS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 18: GLOBAL HOSPITAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 19: GLOBAL HOSPITAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 20: GLOBAL PHARMACY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 21: GLOBAL PHARMACY MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 22: GLOBAL SMART INHALERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 23: GLOBAL SMART INHALERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 24: NORTH AMERICA SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 25: NORTH AMERICA SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 26: EUROPE SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 27: EUROPE SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 28: ASIA PACIFIC SMART INHALERS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 29: ASIA PACIFIC SMART INHALERS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)
TABLE 30: REST OF WORLD SMART INHALERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ THOUSAND)
TABLE 31: REST OF WORLD SMART INHALERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ THOUSAND)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界のスマート吸入器市場予測2019-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆